La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « Auteurs » - entrée « M. Amalric »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
M. Alonso-Alonso < M. Amalric < M. Amboni  Facettes :

List of bibliographic references indexed by M. Amalric

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000103 (2016) S. Ztaou ; N. Maurice [France] ; J. Camon ; G. Guiraudie-Capraz ; L. Kerkerian-Legoff [France] ; C. Beurrier [France] ; M. Liberge ; M. AmalricInvolvement of striatal cholinergic interneurons, M1 and M4 muscarinic receptors in motor symptoms of Parkinson's disease
000401 (2015-10) N. Maurice [France] ; M. Liberge ; F. Jaouen [France] ; S. Ztaou ; M. Hanini [France] ; J. Camon ; K. Deisseroth ; M. Amalric ; L. Kerkerian-Legoff [France] ; C. Beurrier [France]Striatal Cholinergic Interneurons Control Motor Behavior and Basal Ganglia Function in Experimental Parkinsonism
000793 (2014) M. Amalric [France]Targeting Metabotropic Glutamate Receptors (mGluRs) in Parkinson's Disease
000D14 (2013) M. Amalric [France] ; S. Lopez ; C. Goudet ; G. Fisone ; G. Battaglia ; F. Nicoletti ; J-P Pin ; F C AcherGroup III and subtype 4 metabotropic glutamate receptor agonists: discovery and pathophysiological applications in Parkinson's disease.
001020 (2012-04) S. Lopez [France] ; L. Jouve [France] ; N. Turle-Lorenzo ; L. Kerkerian-Legoff [France] ; P. Salin [France] ; M. AmalricAntiparkinsonian action of a selective group III mGlu receptor agonist is associated with reversal of subthalamonigral overactivity.
001468 (2011-08-17) A. Courtiere [France] ; J. Hardouin ; Boris Burle [France] ; F. Vidal [France] ; N. Turle-Lorenzo [France] ; M. Amalric [France] ; T. Hasbroucq [France]Dynamics of Executive Control and Motor Deficits in Parkinsonian Rats
001A12 (2010) B. Greco [France] ; S. Lopez ; H. Van Der Putten ; P J Flor ; M. AmalricMetabotropic glutamate 7 receptor subtype modulates motor symptoms in rodent models of Parkinson's disease.
002236 (2008-09) S. Lopez [France] ; N. Turle-Lorenzo [France] ; Johnston Th [Canada] ; Brotchie Jm [Canada] ; S. Schann [France] ; P. Neuville [France] ; M. Amalric [France]Functional interaction between adenosine A2a and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats
002255 (2008) M. Amalric [France] ; S. Lopez [France]Metabotropic glutamate receptors and Parkinson's disease
002256 (2008) De Leonibus E [Italie] ; F. Manag [Italie] ; F. Giordani [Italie] ; F. Petrosino [Italie] ; S. Lopez [France] ; A. Oliverio [Italie] ; M. Amalric [France] ; A. Mele [Italie]Metabotropic Glutamate Receptors 5 Blockade Reverses Spatial Memory Deficits in a Mouse Model of Parkinson's Disease. : in press [full paper]
002575 (2007) B. Greco ; S. Lopez [France] ; H. Putten ; P. J. Flor ; M. Amalric [France]The role of metabotropic glutamate receptors 7 in several models of Parkinson's disease
002B55 (2005) M. Amalric [France] ; N. Turle-Lorenzo ; S. LopezMetabotropic glutamate receptors : Potential pharmacological targets in Parkinson's disease treatment
002E05 (2005) M. Amalric [France]Metabotropic glutamate receptors: potential pharmacological targets in Parkinson's disease treatment.
002E06 (2005) M. Amalric [France]Metabotropic glutamate receptors as potential pharmacological targets in the treatment of Parkinson's disease.
002E08 (2005) Freichel C. P. [France] ; Ballard T. M. [France] ; R. Coccurello [France] ; M. Amalric [France] ; Moreau J. L. [France] ; W. Spooren [France]Effects of the A2A receptor antagonist KW-6002 on vigilance and motor performance in aged rats and animal models for early- to late-stage Parkinson's disease.
003050 (2003) N. Breysse ; M. Amalric [France]NMDA-metabotropic glutamate receptors interaction in a rat model of Parkinson's disease
003434 (2002) A. Nieoullon [France] ; M. Amalric [France]Les récepteurs dopaminergiques : aspects structuraux et implications fonctionnelles
003522 (2002) A. D. Smith [États-Unis] ; M. Amalric [France] ; G. F. Koob [États-Unis] ; M. J. Zigmond [États-Unis]Effect of bilateral 6-hydroxydopamine lesions of the medial forebrain bundle on reaction time
004696 (1995) C. Baunez [France] ; A. Nieoullon ; M. AmalricIn a rat model of parkinsonism, lesions of the subthalamic nucleus reverse increases of reaction time but induce a dramatic premature responding deficit.
004834 (1995) M. Amalric [France] ; H. Moukhles [France] ; A. Nieoullon [France] ; A. Daszuta [France]Complex Deficits on Reaction Time Performance following Bilateral Intrastriatal 6‐OHDA Infusion in the Rat
004948 (1994) M. Amalric [France] ; A. Ouagazzal [France] ; C. Baunez [France] ; A. Nieoullon [France]Functional interactions between glutamate and dopamine in the rat striatum

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "M. Amalric" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "M. Amalric" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    M. Amalric
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024